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A B S T R A C T   
Background: The use of transcranial Direct Current Stimulation (tDCS) has previously shown promising results for 
reducing craving in cocaine use disorder. In this study we further explored the potential of tDCS as add-on 
intervention in the treatment of cocaine use disorder. 
Methods: In a randomized, placebo-controlled, between subject study, we applied tDCS bilaterally with the 
anodal electrode targeting the right dorsolateral prefrontal cortex (DLPFC; https://clinicaltrials.gov/ct2/show/ 
NCT03025321). Patients with cocaine use disorder were allocated to ten sessions of either active tDCS (n =
29) or sham (n = 30) on five consecutive days. Inhibitory control and risky decision-making were measured via a 
Go-NoGo task and a two-choice gambling task, respectively, each at baseline, one day after all tDCS sessions and 
after three months. Relapse at follow-up and craving were also assessed. 
Results: There was no significant effect of active tDCS on the number of cocaine use days and craving. Relapse 
was frequent among patients who had received either active or sham tDCS (48.0 % and 69.2 %, respectively), 
despite an overall decrease in craving during the first two weeks of treatment. No effects were found on cognitive 
functions. An exploratory analysis for crack cocaine use only revealed that relapse rates were significantly 
reduced after active tDCS (n = 17) as compared to sham (n = 19). 
Conclusions: No beneficial effects of tDCS on number of cocaine use days, craving and cognitive functions were 
found in the present study, but somewhat promising results were obtained regarding relapse rates among crack- 
cocaine users specifically. Further research is required to determine the efficacy of tDCS as a complementary 
treatment in cocaine use disorder.   
1. Introduction 
Psychosocial interventions are currently recommended as first-line 
treatment for cocaine addiction, and there is still little evidence for 
effective pharmacological treatments (De Crescenzo et al., 2018). In 
order to successfully follow psychosocial therapies, certain cognitive 
and emotional skills are required. This can be problematic for substance 
users, since they often show impairments in cognitive control func-
tioning (Franken and van de Wetering, 2015), as a result of prefrontal 
cortex (PFC) dysfunction (Goldstein and Volkow, 2011). Impaired 
cognitive control has been associated with less treatment responsiveness 
(Winhusen et al., 2013) and with relapse in substance use disorders 
(SUDs; Volkow et al., 2016). Therefore, research on addiction treatment 
has recently shifted towards interventions focusing on modulating brain 
activity in the PFC by means of non-invasive brain stimulation (NIBS; 
Nakamura-Palacios et al., 2016). 
Transcranial Direct Current Stimulation (tDCS) over the dorsolateral 
PFC has been one of the protocols of choice in studies on the clinical 
effectiveness of NIBS in addiction (Kekic et al., 2016; Lapenta et al., 
2018). Promising results have been found for craving in a variety of 
SUDs when tDCS was applied over the dorsolateral prefrontal cortex 
(DLPFC; Jansen et al., 2013). For cocaine addiction specifically, five 
sessions of active bilateral tDCS (2 mA, 20 min) over the DLPFC (right 
anodal/left cathodal) reduced craving (Batista et al., 2015). Ten days of 
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tDCS (2 mA, 20 min) over the DLPFC (left anodal/right cathodal) was 
also associated with reduced craving in a small sample of patients with 
cocaine use disorder (De Almeide Ramos et al., 2016). However, no 
effects on craving and relapse were observed after ten tDCS sessions 
(2 mA, 20 min) over the DLPFC (right anodal/left cathodal) in a group 
of patients with cocaine use disorder that reported relatively high 
craving scores at baseline and more years of substance use (Klauss et al., 
2018a). 
Few other studies have attempted to explore the effect of tDCS on 
relapse in addiction. For alcohol use disorder specifically, studies with 
stimulation protocols where the anodal electrode was placed over the 
right DLPFC have generally reported a reduction in risk of relapse 
(Klauss et al., 2014; Klauss et al., 2018b). In addition, a recent 
meta-analysis has indicated that anodal tDCS over the right DLPFC with 
cathodal tDCS over the left DLPFC had the most positive effects on 
smoking behaviour (Kang et al., 2019). For the clinical effectiveness of 
tDCS on addictive behaviour in general, it has been reported that 
multi-session tDCS over the DLPFC is particularly beneficial as 
compared to single session tDCS, but the contribution of other param-
eters such as lateralized neuromodulation (left vs. right) and current 
intensity remains unclear (Song et al., 2019). 
Investigating the underlying mechanism of the therapeutic effects of 
tDCS could help improve the application of NIBS in addiction treatment. 
It has been suggested that therapeutic effects on craving and relapse by 
modulating neuronal activity of the DLPFC is the result of enhanced 
inhibitory control and reduced risky decision-making (Brevet-Aeby 
et al., 2016; Lapenta et al., 2018; Naish et al., 2018; Schluter et al., 
2018). Bilateral tDCS over the DLPFC (right anodal/left cathodal) has 
been associated with less risky decision-making in addiction (Fecteau 
et al., 2014; Pripfl et al., 2013). Also, risky decision-making was reduced 
in patients with cocaine use disorder when bilateral tDCS was applied 
with the anodal electrode over the right DLPFC, but results on 
risk-taking were more inconsistent when the anode was placed over the 
left DLPFC (Gorini et al., 2014). In total, only few studies have investi-
gated tDCS for modulating decision-making in addiction and to the best 
of our knowledge, the effect of tDCS on inhibitory control has not pre-
viously been explored in addiction. 
The current study explored inhibitory control and risky decision- 
making in relation to beneficial effects of tDCS on craving and relapse 
in a representative sample of patients with cocaine use disorder. We 
decided not to exclude patients with additional substance use disorders, 
since cocaine addiction is rarely a stand-alone SUD. It has been reported 
that approximately two-third of patients with cocaine use disorder 
report seeking help for secondary substance use disorders (World Drug 
Report, 2019). In addition, craving was measured by ecological 
momentary assessments (EMA) to collect detailed information about the 
duration and dynamics of the beneficial effects of tDCS (Shiffman et al., 
2008). Since craving is a momentary phenomenon, EMA offers an 
ecologically valid alternative to retrospective self-reports by enabling 
repeated measurement of craving at random moments of the day (Serre 
et al., 2015). 
We hypothesized that beneficial effects of multiple sessions of tDCS 
on relapse will be established by its effects on craving and cognitive 
functions, as shown by less craving, improved inhibitory control and 
reduced risky decision-making after active tDCS. 
The tDCS protocol used in the current study was chosen based on 
previous literature showing that tDCS (2 mA) over the DLPFC (right 
anodal/left cathodal) seemed most effective in some substance use dis-
orders and had the largest effect on risk-taking behaviour. In addition, 
tDCS was applied two times with a 20-minute break in between on each 
intervention day. Performing a second session during the after-effects of 
the first tDCS session (within 20 min) could increase the duration of 
combined after-effects beyond one day (Monte-Silva et al., 2013). We 
therefore expected that the multi-session tDCS protocol employed in the 
current study as add-on treatment in cocaine use disorder would 
decrease the number of relapse days within three months after the 
intervention. 
2. Materials and methods 
This clinical trial was pre-registered with identifier NCT03025321 at 
ClinicalTrials.gov. The study was approved by the Medical Ethics 
Committee of the Erasmus Medical Center, Rotterdam, the Netherlands. 
Detailed information about the materials is provided at https://dx.doi.or 
g/10.17504/protocols.io.bjwhkpb6. 
2.1. Participants 
All participants were fully informed by the principal investigator 
before they signed the written informed consent and entered the study. 
The study was powered for a moderate effect size (f = .25) based on the 
study by Batista et al. (2015). With a two-tailed p-value of 0.05 and a 
power of .80, we estimated to recruit about 80 participants. 
Seventy-eight patients (61 males, 17 females) who met the DSM-5 
criteria for cocaine use disorder as assessed by a clinician were 
recruited between February 2017 and November 2018 from one 
specialized clinic for inpatient SUD treatment in Rotterdam (Antes) 
within one week after arrival. In total, fifty-nine patients (active tDCS n 
= 29, sham tDCS n = 30) completed the intervention week. Reasons for 
drop-out did not differ between groups (e.g. relapse, high load of 
experiment, tDCS side effects). 
The inclusion criteria for the current study were: 1) Males and fe-
males aged between 18 and 65 years; 2) Meeting the DSM-5 criteria for 
cocaine use disorder; 3) The ability to speak, read, and write in Dutch at 
an eight-grade literacy level; 4) Abstinent for at least one week; 5) 
Owner of a smartphone. Exclusion criteria were: 1) Any self-reported 
withdrawal signs or symptoms at baseline; 2) Indications of severe 
psychopathology (i.e. history of psychoses or bipolar disorder) or un-
stable medical disorder as assessed by a physician; 3) A diagnosis of 
epilepsy, convulsions or delirium tremens during abstinence of cocaine; 
4) Any contraindication for electrical brain stimulation procedures (i.e. 
electronic implants or metal implants); 5) Pregnancy or breast-feeding. 
In addition, all participants received treatment as usual in the inpatient 
clinic for approximately three weeks, including psychosocial therapies 
conducted by professional practitioners – sometimes combined with 
adjunctive pharmacotherapy including benzodiazepines and disulfiram 
and, if necessary, antidepressants, anxiolytics, antihypertensive and 
gastric medication (similar to Klauss et al., 2018). 
2.2. Experimental design 
The current study had a double-blind, randomized, sham-controlled 
design in which patients with cocaine use disorder received a total of ten 
tDCS sessions (active or sham) on five consecutive mornings in the week 
after arrival in the inpatient clinic (Fig. 1). Participants were first 
randomly assigned to either sham or active tDCS. Then, before the tDCS 
sessions, participants completed questionnaires regarding de-
mographics, past drug use (Addiction Severity Index; ASI, Alcohol Use 
Disorders Identification Test; AUDIT), and cocaine addiction severity 
(Obsessive Compulsive Drug Use Scale – cocaine version; OCDUS). In 
addition, they performed two behavioural tasks (i.e., an inhibitory 
control and risky decision-making task) before the first session and one 
day after the last tDCS session. Participants were furthermore asked to 
answer questions about craving in an application on their mobile phones 
(EMA) for two weeks, starting the day of the first tDCS session. 
Three months after the tDCS intervention, participants returned to 
the clinic in order to verify cocaine use in the past three months. Upon 
follow-up, participants completed the same behavioural tasks as at 
baseline. 
I. Verveer et al.                                                                                                                                                                                                                                  




Patients were followed-up 90 days after the last tDCS session 
regarding cocaine use relapse. Drug use was defined as the number of 
self-reported days that patients had used cocaine in the past 90 days. In 
addition, relapse rates were defined as the percentage of participants 
who had used cocaine (yes or no) in the last 90 days. This information 
was gathered by a telephone call, during which an appointment was 
made for the follow-up session in the clinic. If patients could not be 
reached by telephone, they were contacted by email. In case of no 
response, we contacted a family member, to request further information 
on how to reach the patient. During the follow-up session in the clinic, 
patients were asked again how many days in the past 90 days they had 
used cocaine, which was then verified with urine drug screens. 
2.3.2. EMA: craving 
The LifeData platform (www.lifedatacorp.com) was used to develop 
the application for this study and to securely collect data. After partic-
ipants had downloaded the application on their smartphone during the 
first session, they received random prompts three times a day between 
10 AM and 10 PM for 14 consecutive days to complete a random 
assessment (RA). Random assessments that were not completed within 
120 min after the notification disappeared and were marked as missed. 
During random assessments, participants were asked to indicate their 
craving for cocaine at that moment on a Likert scale ranging from 0 to 
100. In addition, participants were asked if they had used cocaine or any 
other drug, alcohol or cigarettes since the last time that they had filled 
out a random assessment. Also, questions about general mood and 
specific affects were included, but these are beyond the scope of this 
paper. 
2.3.3. Inhibitory control: Go-NoGo task 
Previous studies have indicated that patients with cocaine use dis-
order perform worse on the Go-NoGo task as compared to healthy 
controls (e.g. Hester et al., 2013). The current study used a cocaine 
related Go-NoGo task to measure inhibitory control, based on the 
paradigm used in Luijten et al. (2011). During this task, participants 
were presented with a series of cocaine-related and neutral pictures. 
Participants were instructed to press a button with their index finger as 
fast as possible for Go trials, and to inhibit their response for the unex-
pected NoGo trials (25 % of all trials). See Fig. 2 and Materials in 
https://dx.doi.org/10.17504/protocols.io.bjwhkpb6 for more details 
about the task. 
2.3.4. Risky decision-making: two choice gambling task (TCGT) 
An adjusted version of the computerized probabilistic two-choice 
gambling task (TCGT) was used for the current study (Schuermann 
et al., 2012). Participants were instructed to gain as many points as 
possible by choosing between two options that were presented on a 
computer screen (Fig. 3). Trial A represented a high-risk option (left) 
with a higher chance of losing more points than the low-risk option 
(right). Trial B depicts two options with equal chances of losing, but 
more points in the high-risk option (left) than the low-risk option (right). 
Trial C presents an option with low points (right) and a high chance of 
losing, and an option with high points and a low risk of losing (left). See 
https://dx.doi.org/10.17504/protocols.io.bjwhkpb6 for further details 
about the task. 
2.4. Transcranial direct current stimulation 
Participants received tDCS by an electric DC-plus stimulator (Neu-
roConn, Ilmenau, Germany) via a pair of carbon silicon electrodes with a 
thick layer of high-conductive EEG gel underneath them (35 cm2). 
During each session, tDCS was applied two times for 13 min (2 mA) with 
a 20-minute rest interval between the stimulations (Klauss et al., 2014; 
Shahbabaie et al., 2018), while participants watched a neutral docu-
mentary in Dutch. Each 13-minute stimulation included a 30 s ramp up 
at the beginning and ramp down at the end. Monte-Silva et al. (2013) 
have reported that this protocol can extend after-effects of tDCS. The 
anodal electrode was placed over the F4 and the cathodal electrode was 
placed over the F3 based on 10–20 international system. Beneficial ef-
fects were found on relapse and craving with this right anodal/left 
cathodal positioning over the DLPFC (Klauss et al., 2014; Jansen et al., 
2013; Shahbabaie et al., 2014). 
The control group received sham tDCS by the DC-plus stimulator. In 
the sham condition, the electrodes were positioned at the same locations 
as in the active tDCS condition, but in this case the stimulator was 
Fig. 1. Flow-chart of the experimental procedure. Participants were recruited from the inpatient addiction clinic, signed the informed consent, and were randomized 
to receive either sham or active transcranial Direct Current Stimulation (tDCS). The intervention week comprised 10 sessions of bilateral tDCS with the anodal 
electrode over the right DLPFC (2mA, 2x 13 min stimulation with a 20-minute rest interval in between) on five consecutive days. 
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gradually turned off after 30 s. Since the itching sensation of tDCS is 
often only experienced initially during stimulation, it was expected 
subjects remained blinded of the stimulation condition they received (e. 
g. Gandiga et al., 2006; Woods et al., 2016). The experimenter was also 
blinded from the tDCS condition. That is, the codes that can automati-
cally activate sham or active tDCS, were randomly assigned to partici-
pant numbers by an independent researcher. 
2.5. Data analyses 
2.5.1. Relapse 
An independent samples t-test was performed in SPSS to analyse the 
average number of days participants had used cocaine in the 3 months 
after the tDCS intervention. An additional analysis was performed to test 
whether relapse rates, defined as the percentage of people that had 
relapsed within the 3 months after the intervention, differed for the 
active and sham tDCS group using the chi-square fisher exact test. 
2.5.2. Craving 
Multilevel analysis was performed in R (R Core Team, 2018) using 
the lme4 package (Bates et al., 2014) to fit the nested data structure of 
Time within individuals (Level 1), and Group (sham vs. active tDCS) at 
Level 2. Multilevel modelling also allowed us to include data points of 
individuals with missing data. Missing data is almost inevitable in EMA 
studies, since most participants miss at least some prompts. 
The outcome variable in this analysis was average craving a day. 
Time (day 1–14) was defined at Level 1 and patients at Level 2, with 
Group (sham vs. active tDCS) as a Level 2 predictor variable (see Hox, 
2010). For the analyses, first a baseline model (M0) was fitted to the data 
with random intercepts. The baseline model was used to assess whether 
Fig. 2. Example of a cocaine related and neutral picture in the Go-NoGo task. The colours of the frames (either blue or yellow) indicate Go and NoGo trials.  
Fig. 3. Example of the probabilistic two choice gambling task.  
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multilevel analysis was required, by testing if the variance at Level 2 was 
significant. In the second model (M1) the Level 1 predictor Time was 
added to the model. In the third model (M2) random slopes were added 
for Time. The fourth model (M3) included the Level 2 predictor Group. 
Finally, the fifth model (M4) was extended by a cross-level interaction of 
Time at Level 1 and Group at Level 2 to assess whether the effect of time 
varied across groups. The fit of the models was analysed by testing the 
difference in deviance across models. In addition, the assumptions of 
normality and linearity were assessed by inspecting the residuals of each 
best fitted model. Unless otherwise reported, the assumptions were met. 
2.5.3. Behavioural tasks 
For behavioural data generated during the Go-NoGo task and the 
TCGT, multilevel analyses were again performed in R using the lme4 
package. For all outcome measures, Time (pre, post, and follow-up) was 
defined at Level 1 and patients were defined at Level 2 with Group (sham 
tDCS vs active tDCS) as predictor variable. Similar to the outcome of 
craving, models M0, M1, M2, M3 and M4 were fitted to behavioural 
outcomes. 
For the outcome measures of the Go-NoGo task, different models 
were fitted to accuracy scores, reaction times on Go trials, and post error 
reaction times. Accuracy was defined as the percentage of correct NoGo 
trials. For both accuracy and reaction times on Go trials, Picture Type 
(cocaine vs. neutral) was defined as Level 1 variable in addition to Time. 
The main outcome variable of the TCGT was the average number of 
points won per trial. In addition, a separate model was built for high-risk 
choices, with risk-taking calculated as the percentage of times that 
participants choose high-risk options over low-risk options on trials A 
and B (Fig. 3). Trial C (Fig. 3) can be considered as control trial, since 
both options contain a low level of risk-taking. 
2.5.4. Adverse effects tDCS 
After each tDCS session, participants were asked to indicate how 
much they experienced any of the following adverse effects on a 5-point 
Likert scale (ranging from none (1) to extreme (5) sensations): itching, 
burning, or tingling sensations, difficulties with concentrating, acute 
mood changes, sleepiness, neck pain, and headache. An independent 
samples t-test with Group (Active vs. Sham tDCS) as between-subject 
factor was performed for average intensity of adverse effects experi-
enced by each participant. No differences between the groups (active 
tDCS vs sham) were observed regarding adverse effects. 
3. Results 
Demographical data and patterns of drug use are presented in 
Table 1. The active tDCS and sham group did not differ in baseline 
characteristics. It was furthermore confirmed that multilevel analyses 
could be performed for all outcomes, as the multilevel models with 
random intercepts fitted the data (i.e. variance at Level 2 was 
significant). 
3.1. Relapse 
There were no mismatches between urine drug screens and answers 
patients gave to the question whether they had relapsed or not. The 
number of days that participants had used cocaine did not differ be-
tween groups (t(49) = 1.30, p = 0.20). Overall, relapse rates within 90 
days after the 10 tDCS sessions were high for both the active (48.0 %, n =
12) and sham (69.2 %, n = 18) tDCS group. There was no significant 
difference in relapse rates between both groups for the 90 days follow-up 
(odds-ratio = 0.42, X2(1) = 2.37, p = 0.12). 
Since previous studies analysed relapse rates for patients who use 
crack cocaine (Batista et al., 2015; Klauss et al., 2018), we decided to 
perform an exploratory analysis including only crack cocaine users 
(active tDCS n = 17; sham n = 19). These results show that relapse was 
lower for the active tDCS group (41.2 %, n = 7) as compared to the sham 
tDCS group (73.7 %, n = 14). The odds-ratio for the group of crack 
cocaine users was 0.26 (X2(1) = 3.90, p = 0.05). 
The group of patients who used cocaine in the form of crack were 
older as compared to the group who used powder (t(57) = -2.48, p =
0.02). Also, 11 out of 12 female participants from our sample were 
crack-cocaine users. Taking these variables into account did not affect 
the results for relapse. Furthermore, baseline comparisons between the 
active tDCS and sham groups within the sample of patients who used 
cocaine in the form of crack revealed that there were no differences in 
baseline characteristics (e.g. age, gender, years of use, age of onset, 
OCDUS scores, other substances used). 
3.2. Ema 
3.2.1. Compliance 
The total number of completed random assessments for day 1 to day 
14 was 1250 out of 2775 random assessments. Therefore, the compli-
ance rate for completed random assessments was 45.0 %. The compli-
ance rate was higher for the active tDCS group (49.6 %) as compared to 
the sham tDCS group (40.5 %), with an odds ratio of 0.69 (X2(1) =
22.95, p < .001). 
3.2.2. Craving 
The third model (M2) with random intercepts and slopes for time, 
Table 1 
Socio-demographic characteristics of the total sample of cocaine users (n = 59), 
subdivided in subjects that received the transcranial Direct Current Stimulation 
intervention (active tDCS: n = 29) or the sham intervention (sham tDCS: 
n = 30).    














Gender (% male)  70.0 89.7 Fisher =
1.0 
0.10 
Years of Education 
(%) 
0− 8 years 6.7 17.2 X2 =
3.04 
0.22  
9− 14 years 46.7 27.6    
above 14 
years 
46.7 55.2   
Age of onset cocaine 








Number of years 









Days of abstinence 
before study 




































How cocaine is used 
(%) 
Snorting 23.3 37.9 X2 =
1.80 
0.41  
Smoking 63.3 55.2    
Both 13.3 6.7   










36.7 34.5    
Multiple 43.3 41.4   
Type of other 
substances used 
(%) 
Alcohol 33.3 36.7 X2 =
3.85 
0.43  
Cannabis 26.7 28.3    
Heroin 10.0 10.0    
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including Time as Level 1 predictor, was the best fitted model for 
average craving a day (Supplementary file; Table 3). There was an 
overall decrease of craving over time observed in the 14 days after the 
first tDCS or sham session, with an average decrease of 1.29 (t(52) =
-5.00, p < .001). The results show no indication of significant differ-
ences between the sham and active tDCS group in craving over time. 
Additionally, the results for craving did not differ for participants who 
had relapsed or not three months after active or sham tDCS. Finally, 
there was no difference between the active and sham tDCS group in 
craving over time if only crack-cocaine users were included for analyses. 
3.2.3. Inhibitory control 
For all behavioural measures of inhibitory control as measured by 
the Go-NoGo task (Table 2), the results indicate that the third model 
(M2) was the best fitted model for the data. The third model for accuracy 
on NoGo trials (Supplementary file; Table 4) indicates that accuracy 
increases over time from baseline to follow-up with an average of 5.36 (t 
(58) = 2.89, p < .01). In addition, M2 for reaction times during Go trials 
(Supplementary file; Table 4) suggests an average decrease of 15 ms 
from pre- to post intervention (t(57) = -2.92, p < .01). Finally, there was 
evidence of a general post-error slowing: reaction times post error trials 
were on average 27 ms slower than reaction times post correct trials (t 
(154) = -11.90, p < .001). The final model (M4) was never the best 
fitted model, and therefore no significant differences over time between 
groups were found for all inhibitory control outcomes. 
3.2.4. Risky decision-making 
Descriptive statistics for outcome measures on the TCGT can be 
found in Table 2. The baseline model was the best fit for the average 
number of points won per trial (Supplementary file: Table 5). For per-
centage of high-risk choices, the second model (M1) with Time as fixed 
effect was the best fitted model (Supplementary file: Table 5). The lack 
of significant cross-level interaction effects indicates that risky decision- 
making was unaffected by tDCS. 
4. Discussion 
The present study explored multi-session tDCS over the DLPFC as 
add-on treatment for cocaine use disorder and its effects on cognitive 
functions. There was no indication of a decrease in the number of 
cocaine use days after three months for patients with cocaine use dis-
order who had received active tDCS as compared to sham. In line with 
the non-significant findings of tDCS on drug use in cocaine use disorder, 
no beneficial effects of tDCS on craving and cognitive functions were 
found in the present study. 
4.1. Cocaine use during follow-up 
The assessment of complete abstinence has been the golden standard 
to measure treatment efficacy; however, relapses often occur after 
treatment and a reduction of drug use to less harmful levels can be a 
positive outcome (Ekhtiari et al., 2019). We therefore decided to define 
drug use by an informative outcome measure, namely the number of 
days participants had used cocaine in the three months following tDCS 
treatment. Yet, in order to compare the results to previous reported 
treatment efficacy of tDCS in cocaine addiction (Klauss et al., 2018a), we 
also determined binary relapse rates. 
Relapse rates three months after active tDCS (48.0 %, n = 12) and 
sham (69.2 %, n = 18) were similar to previously reported relapse rates 
in a sample of patients with cocaine use disorder (52.9 % active tDCS vs. 
66.7 % for sham; Klauss et al., 2018a). An exploratory analysis for the 
crack-cocaine users in the current study revealed that relapse rates were 
significantly lower after active tDCS (41.2 %, n = 7) as compared to 
sham (73.7 % n = 14), but this was not the case for the powder-cocaine 
users. Perhaps, tDCS has better treatment success in patients who use 
cocaine in the form of crack instead of powder, although the difference 
in relapse rates after active vs. sham tDCS had previously not reached 
significance in crack-cocaine users (Batista et al., 2015; Klauss et al., 
2018a, 2018b). It is unclear why in the current study tDCS may have 
been more effective in crack-cocaine users and caution should be taken 
when interpreting these results as relapse rates are still high after active 
tDCS for patients who used cocaine in the form of crack and the sample 
of this group was small (n = 36). Arguably, larger sample sizes are 
needed, with an equal number of patients who use cocaine in the form of 
crack and powder, to increase the power and to be able to better detect 
an effect of tDCS on both crack- and powder cocaine addiction, if 
present. 
It may also be useful to consider alternative outcome measures of 
relapse. Future investigations may use the percentage of relapse days 
and the time until the first relapse as (additional) informative primary 
outcome measures of treatment success. Alternatively, self-set treatment 
goals of patients could be considered to determine individual definitions 
of treatment success, since these goals may differ per patient depending 
on the preference and obtainability of treatment outcomes. 
4.2. Craving 
Craving levels for patients with cocaine use disorder were measured 
with EMA while participants were inside the inpatient addiction clinic. 
No significant difference between the active tDCS and sham group was 
found on craving levels, but we observed a general decrease of craving 
over time after both active and sham tDCS. These results are consistent 
with observations from Klauss et al. (2018a). It could be the case that 
there was a floor effect of craving levels by the lack of environmental 
cues or stress inside the clinical setting (den Uyl et al., 2017). Future 
studies could best measure craving with EMA outside the clinic. If one 
decides to measure craving while patients are inside the clinic, it would 
be recommended to induce craving by means of cue-exposure, as a 
reflection of craving levels outside the clinic (Ekhtiari et al., 2019). 
4.3. Cognitive functions 
To the best of our knowledge, this is the first time that the effect of 
multi-session tDCS on inhibitory control has been investigated in 
addicted patients (Naish et al., 2018; Schluter et al., 2018). Inhibitory 
control improved for both groups over time, as indicated by increased 
accuracy and faster reaction times on the Go-NoGo task. Yet, tDCS had 
no additional effect on improved inhibitory control. It has been sug-
gested that the DLPFC would be more involved in proactive rather than 
reactive response inhibition on the Go-NoGo task (Brevet-Aeby et al., 
Table 2 
Descriptive data for behavioural outcomes Go/NoGo task and TCGT.   
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trials and RT on trials post erroneuous trials in ms. 
Mean (SD) for win per trial and % of high risk choices on the TCGT. 
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2016). However, the current study provides no evidence for this hy-
pothesis. Alternatively, tDCS may be more effective when applied during 
the task (online) instead of before or after (offline). It has been reported 
that the effects of anodal tDCS may be particularly increased after online 
stimulation as compared to offline stimulation for response accuracy in 
patients (Dedoncker et al., 2016). 
We also found no effect of multiple tDCS sessions on risky decision- 
making in patients with cocaine use disorder. For both healthy and 
addicted individuals it has been reported that risky decision-making 
decreased after bilateral tDCS with the anodal electrode over the right 
DLPFC. However, there have been exceptions where tDCS over the 
DLPFC did not effectively reduce risky decision-making (Gorini et al., 
2014; Pripfl et al., 2013). This seems particularly the case when 
gambling paradigms are used, involving indications of the reward 
probability before decisions are made, such as the Risk Task (Fecteau 
et al., 2014) and the TCGT. In fact, active tDCS even increased 
risk-taking behaviour in marijuana users during the Risk Task (Boggio 
et al., 2010), and in smokers during the TCGT (Verveer et al., Unpub-
lished results). Inconsistent findings may therefore depend on task 
characteristics. Clearly, more research is needed to better understand 
how risky decision-making is involved in therapeutic effects of tDCS. 
4.4. Limitations 
The current results should be interpreted with several limitations in 
mind. Although the sample size was slightly larger as compared to 
previous studies on tDCS in cocaine use disorder, the drop-out rate for 
follow-up sessions reduced the power for relapse outcomes. Another 
limitation is the relatively low EMA compliance rate. This may not come 
as a surprise, given the marginalized population of patients with (crack) 
cocaine use disorder. However, as participants were inpatients and other 
addiction studies have reported a higher average compliance of 69.8 % 
(Jones et al., 2019), we would have expected higher compliance rates. It 
is challenging to increase compliance rates, as it remains unclear what 
factors affect EMA compliance rates in populations with an addiction, 
(Jones et al., 2019). Nevertheless, EMA can be regarded as a strength of 
study design, since individual patterns of craving over time can be 
estimated in an ecologically valid manner. Finally, almost all (but 2) 
participants were tobacco smokers, and the timing of smoking in rela-
tion to each session could have affected tDCS effects and cognitive 
control performance. Future studies should control for this possibility. 
4.5. Future directions tDCS 
It is important to note that still little is known about the contribution 
of different tDCS parameters to the clinical effectiveness of tDCS in 
addiction. The effects of anodal and cathodal stimulation have varied 
considerably, depending on current brain state, inter-individual differ-
ences in neurophysiology, clinical status, cognitive capacity, and stim-
ulation parameters such as the duration and intensity of tDCS 
stimulation (Ekhtiari et al., 2019; Jamil et al., 2017; Luigjes et al., 2019). 
It could well be that more than a total of ten sessions may be needed to 
induce long-term after-effects. For example, typically 20–30 neuro-
stimulation sessions are considered for the treatment of major depres-
sion (Luigjes et al., 2019). Additionally, a recent study in smokers 
showed that 20 sessions of tDCS resulted in similar abstinence rates as 
bupropion treatment (Behnam et al., 2019). The results of this study also 
indicated that weekly boosting sessions after the actual tDCS interven-
tion may increase the effectiveness of tDCS. More research is needed to 
provide further insights in the optimal tDCS protocol. 
Another particularly promising way forward is to consider individual 
differences in order to optimize stimulation parameters for addiction 
treatment. One approach could be to fit the tDCS protocol to the pa-
tients’ neurobiological or cognitive profile (Luigjes et al., 2019). For 
example, it could be investigated whether tDCS treatment outcomes 
may be modulated by baseline DLPFC-striatal functional connectivity, as 
is the case for TMS in the treatment of depression (Avissar et al., 2017). 
In addition, motivation to quit drug use and the engagement in treat-
ment may be taken into account in future studies, as these factors could 
affect the effect of tDCS on treatment success (De Souza Brangioni et al., 
2018). 
4.6. Conclusions 
The findings thus imply that multiple sessions of bilateral tDCS with 
the anodal electrode over the right DLPFC has no significant beneficial 
effects on relapse and craving, or on cognitive control functions in pa-
tients with cocaine use disorder. However, some evidence was provided 
that relapse rates decrease after tDCS for crack-cocaine users specif-
ically. Future investigations should examine different effects of tDCS 
depending on type of substance use, age, severity of substance use, and 
motivation to quit. 
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